ConductScience.org, home

Gene · 3601

Papers2,328

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

361 to 380 of 2,328

Download this page as JSON
TitleJournalYearPMIDFound bySource
Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma.Mol Cancer202336627693PubTator, text miningPubMed
Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children.Can J Cardiol202336626979PubTator, text miningPubMed
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer.Cancer Discov202336622087PubTator, text miningPubMed
Structural basis for the mutation-induced dysfunction of the human IL-15/IL-15α receptor complex.Phys Chem Chem Phys202336607223PubTator, text miningPubMed
Phenotypic signatures of immune selection in HIV-1 reservoir cells.Nature202336599977PubTator, text miningPubMed
Longitudinal proteomic profiling of the inflammatory response in dengue patients.PLoS Negl Trop Dis202336595532PubTator, text miningPubMed
Advanced T and Natural Killer Cell Therapy for Glioblastoma.J Korean Neurosurg Soc202336588388PubTator, text miningPubMed
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors.Cancer Commun (Lond)202336585761PubTator, text miningPubMed
Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells.Nat Biomed Eng202336509913PubTator, text miningPubMed
Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study.Clin Chem202336508319PubTator, text miningPubMed
Evaluation of the clinical molecule anti-human-PD-L1/IL-15 KD033 in the human-PD-1/PD-L1-expressing murine model demonstrates PD-L1 targeting of IL-15 in vivo.Cancer Immunol Immunother202336454338PubTator, text miningPubMed
Designing Cancer Immunotherapies That Engage T Cells and NK Cells.Annu Rev Immunol202336446137PubTator, text miningPubMed
Allogeneic natural killer cell therapy.Blood202336416736PubTator, text miningPubMed
Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection.Emerg Microbes Infect202336408648PubTator, text miningPubMed
Beyond Adaptive Alloreactivity: Contribution of Innate B Cells to Allograft Inflammation and Rejection.Transplantation202336404414PubTator, text miningPubMed
The emerging field of oncolytic virus-based cancer immunotherapy.Trends Cancer202336402738PubTator, text miningPubMed
Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting Cells.J Immunother202336378147PubTator, text miningPubMed
A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy.Blood Adv202336332004PubTator, text miningPubMed
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy.Nat Biotechnol202336316485PubTator, text miningPubMed
The Acute Cytokine Response to 30-Minute Exercise Bouts Before and After 8-Week Endurance Training in Individuals With Obesity.J Clin Endocrinol Metab202336285617PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3601/papers?page=19